A new Test called protein misfolding cyclic amplification (PMCA) uses for to distinguish PD from other conditions paved a promising outcome of Treatment .
" Previous studies suggested that the fibrils produced in people with Parkinson’s disease and MSA may adopt slightly different shapes. To see if PMCA could be used to distinguish the different fibrils, the scientists tested CSF samples from people known to have Parkinson’s disease, MSA, and other neurological diseases not related to alpha-synuclein. " Excerpt from Study .
This underlines another way of detecting these conditions when applying to the appropriate clinical care .
For more Info :
Harnessing Probiotics to Deliver Parkinson’s Disease Treatment
New Method May Help Diagnose Parkinson’s Using a Blood Test
